BPH Treatment in Europe Versus the U.S.
In Europe, the use of alpha-blockers has increased, especially since the introduction of tamsulosin, which is easier to take and has fewer side effects. (In the U.S., alpha-blockers already make up 85% of prescriptions for BPH.)
Doctors, especially in Germany and France, prescribe plant (herbal) extractsusually saw palmettomore commonly than in the U.S. Finasteride use has remained fairly constant. Transurethral resection of the prostate (TURP) is the most commonly used surgical treatmentin both the U.S. and Europe. Minimally invasive techniques, which make up about 6% to 9% of surgeries, are not yet readily performed on either continent, but evidence is accumulating and techniques are being developed that may change this.









